期刊文献+

马传染性贫血病毒N-连接糖基化回复突变的感染性克隆构建 被引量:1

Construction of an Infectious Clone of Equine Infectious Anemia Virus by N-glycosylation Revers-mutations
下载PDF
导出
摘要 根据马传贫强毒株EIAV-L和疫苗株EIAV-FDD表面蛋白gp90的N-连接糖基化的变化规律,采用PCR定点突变的方法,对全长感染性克隆pLGFD3-8上的N-连接糖基化的差异区域进行改造后,构建成含有3个N-连接糖基化位点突变的感染性克隆pLGN191N236N246。将其转染驴胎皮肤细胞(FDD),通过用逆转录酶活性、间接免疫荧光和RT-PCR方法检测而确定其感染性。结果表明,在FDD细胞中盲传三代后,在细胞培养物中可检测到逆转录酶活性,RT-PCR和间接免疫荧光检测均呈阳性,电镜下见到典型的EIAV颗粒。这一结果可能对N-连接糖基化在我国马传贫弱毒疫苗致弱机理的作用研究而奠定良好的基础。 To elucidate the role of N-glycosylation in fetal donkey dermal cell (FDD)-attenuated equine infectious anemia virus (EIAV), we constructed an N-glycosylation reverse-mutation molecular clone, pLGN191N236N246. This viral molecular clone was derived from the infectious clone pLGFD3-8 by site-directed mutagenesis. This clone was used to transfect fetal donkey dermal (FDD) cells. Infectious characteristics of transfectants were monitored by RT-PCR, indirect immune fluorescence and reverse transcriptase activity assay. After three passages in FDD cells, viral replications in the superuatant of cell cultures were detected by all the above three methods and viral particles were clearly observed by electron microscopy. The construction of the N-glycosylation reverse-mutation infectious clone provides a solid basis for further study of the mechanism of attenuated pathogenesis and increased immune protection of EIAV attenuated vaccines.
出处 《微生物学报》 CAS CSCD 北大核心 2008年第3期287-292,共6页 Acta Microbiologica Sinica
基金 国家“973项目”(2001CCA00600) 黑龙江省发展高新技术产业专项资金项目(FW05B007)~~
关键词 马传染性贫血病毒 N-连接糖基化 定点突变 感染性克隆 equine infectious anemia virus (EIAV) N-glycosylation site-directed mutagenesis infectious clone
  • 相关文献

参考文献15

  • 1Leroux C, Cadorea J, Montellaro RC. Equine infectious anemia virus (EIAV): what has HIV's country cousin got to tell us? Vet Res, 2004, 35: 485-512. 被引量:1
  • 2Losman B, Biller M, Olofsson S,et al. The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant. FEBS Lett, 1999, 454: 47-52. 被引量:1
  • 3Losman B, Bolmstedt A, Schonning K,et al. Protection of neutralization epitopes in the V3 loop of oligomeric human immu nodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.AIDS Res Hum Retroviruses, 2001, 17: 1067-1076. 被引量:1
  • 4Mellquist JL, Kasturi L, Spitalnik SL, et al.The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry, 1998, 12: 6833-6837. 被引量:1
  • 5Ohgimoto ST, Shioda K,Mori E,et al.Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity. J Virol, 1998, 72: 8365-8370. 被引量:1
  • 6Schonning K, Jansson B, Olofsson S,et al.Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.J Gen Virol, 1996, 77: 753-758. 被引量:1
  • 7Sjolander S, Bolmstedt A, Akerblom L, et al.N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity. Virology, 1996, 215: 124-133. 被引量:1
  • 8Desrosiers RC. Strategies used by human immunodeficiency virus that allow persistent viral replication. Nat Med, 1999, 5: 723-725. 被引量:1
  • 9Kahler S.Immunologic response to EIAV offers hope for AIDS treatment. JAm VetMedAssoc, 1992, 201(11):1672-1673 被引量:1
  • 10Stephen DJ,Embretson DC,Anderson JI,et al.Sequence analysis and acute pathogenicity of molecular cloned SIVSMM-PBJI4. Nature, 1990, 345: 636-639. 被引量:1

同被引文献2

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部